CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models
PLOS One · 19.03.2026 · 21 (3) · e0344446
DOI: 10.1371/journal.pone.0344446 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 19.03.2026. Verfasst von Jiao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China. Hauptthemen laut MEDLINE: Islets of Langerhans, Immunomagnetic Separation, Cell Adhesion Molecules, Cell Separation. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Health Commission Scientific Research Project, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
Islet transplantation represents a promising therapeutic approach for type 1 diabetes through restoration of endogenous insulin production. However, efficient purification of islets from surrounding exocrine tissue remains a critical challenge, as current methodologies often compromise purity, yield, or islet viability.
Methods
We exploited the differential expression of CD99 between murine pancreatic exocrine tissue (high expression) and islets (negligible expression) to develop a novel immunomagnetic negative selection protocol. Expression patterns were validated using immunofluorescence, immunohistochemistry, and western blot. Subsequently, streptavidin-conjugated magnetic beads coupled with biotinylated anti-CD99 antibodies were employed to selectively deplete CD99-positive exocrine cells from pancreatic digests, thereby enriching viable islets.
Results
This approach achieved a remarkable increase in islet purity from 10.4 ± 3.9% to 93.0 ± 1.4% ( P < 0.0001). Purified islets maintained structural integrity and demonstrated robust glucose-stimulated insulin secretion in vitro , comparable to islets isolated via conventional Ficoll density gradient centrifugation ( P > 0.05). In a syngeneic transplantation model, 400 islet equivalents effectively reversed streptozotocin-induced diabetes, with therapeutic efficacy equivalent to Ficoll-purified islets ( P > 0.05).
Conclusions
Our CD99-targeted immunomagnetic negative selection offers a novel, highly specific, and effective alternative for obtaining high-quality islets, as demonstrated by their excellent functional performance both in vitro and in vivo .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
- Gastrointestinal Department, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
ORCID-Profile: Lei Zhang
Förderung
- Jiangsu Provincial Health Commission Scientific Research Project
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Liu, J., Li, D., Huang, J., Hu, Y., & Zhang, L. (2026). CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models. PLOS One, 21(3), e0344446. https://doi.org/10.1371/journal.pone.0344446
Vancouver
Liu J, Li D, Huang J, Hu Y, Zhang L. CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models. PLOS One. 2026;21(3):e0344446. doi:10.1371/journal.pone.0344446
BibTeX
@article{Liu2026,
author = {Liu, Jiao and Li, Dong and Huang, Jiayong and Hu, Yangxin and Zhang, Lei},
title = {CD99-targeted immunomagnetic negative selection: A novel strategy for high-purity pancreatic islet isolation in murine models},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0344446},
doi = {10.1371/journal.pone.0344446}
}
EUVIMED